Tri Locum Partners LP
CIK 1826434 · View on SEC EDGAR ↗
- Portfolio value
- $813.2M
- Positions
- 19
- As of
- June 30, 2026
#2,800 of 9,443 by 13F value · top 29.7%
Portfolio value QoQ: +14.1% 13F does not disclose cash
- Top 10 holdings weight
- 80.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 17
- Effective number of positions
- 12.8
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 32.75% Est. buys $297,935,607 · sells $249,833,449
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 32.2% still held
- New positions
- 5
- Increased
- 8
- Decreased
- 6
- Closed
- 3
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +31.9% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 99.8% · Options excluded: 0.0%
Sector breakdown
Healthcare
90.6%
Other/Unmapped
9.4%
Full portfolio 19 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson Common Stock | $107,923,282 | 13.27% | 424,945 | $6,602,169 | Up ×1 | ||
| VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $100,235,643 | 12.33% | 201,791 | $42,491,769 | Up ×1 | ||
| LLY Eli Lilly and Company Common Stock | $91,794,777 | 11.29% | 76,532 | $34,957,590 | Up ×1 | ||
| Unknown issuer (CUSIP: K08588103) | $69,011,133 | 8.49% | 258,740 | Up ×1 | |||
| DXCM DexCom, Inc. - Common Stock | $55,259,261 | 6.80% | 820,479 | $11,414,939 | Up ×2 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $53,680,019 | 6.60% | 219,308 | $43,181,173 | Up ×1 | ||
| JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | $53,427,868 | 6.57% | 221,720 | $23,432,628 | Up ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $43,985,837 | 5.41% | 866,716 | Up ×1 | |||
| ARGX argenx SE - American Depositary Shares | $38,591,521 | 4.75% | 41,596 | $15,490,062 | Up ×1 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $36,659,187 | 4.51% | 68,273 | $-17,408,982 | Down ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $28,433,224 | 3.50% | 151,822 | Up ×1 | |||
| UTHR United Therapeutics Corporation - Common Stock | $25,480,098 | 3.13% | 47,026 | $-16,247,905 | Down ×3 | ||
| TEVA Teva Pharmaceutical Industries Limited American Depositary Shares | $25,302,770 | 3.11% | 746,835 | $-5,449,991 | Down ×2 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $20,665,720 | 2.54% | 328,340 | $2,946,672 | Up ×1 | ||
| ISRG Intuitive Surgical, Inc. - Common Stock | $19,081,879 | 2.35% | 47,983 | $-51,564,839 | Down ×1 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $16,526,860 | 2.03% | 194,000 | Up ×1 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $11,767,006 | 1.45% | 120,712 | $-446,963 | Down ×2 | ||
| BBNX Beta Bionics, Inc. - Common Stock | $7,730,700 | 0.95% | 493,344 | Up ×1 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $7,667,332 | 0.94% | 162,996 | $682,119 | Down ×1 | ||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ISRG | Trimmed | -105K | -$51.6M |
| VRTX | Bought more | +72K | +$42.5M |
| LLY | Bought more | +15K | +$35.0M |
| JAZZ | Bought more | +63K | +$23.4M |
| MDGL | Trimmed | -35K | -$17.4M |
| UTHR | Trimmed | -23K | -$16.2M |
| ARGX | Bought more | +10K | +$15.5M |
| DXCM | Bought more | +122K | +$11.4M |
| JNJ | Bought more | +10K | +$6.6M |
| TEVA | Trimmed | -274K | -$5.4M |
1 position hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| DHR | March 31, 2026 | 346,875 | $79,406,625 | 12.9% |
| TMO | June 30, 2026 | 132,413 | $65,084,962 | 23.8% |
| ASND | June 30, 2026 | 255,332 | $58,402,088 | -3.3% |
| BSX | March 31, 2026 | 520,508 | $49,630,438 | -21.2% |
| IONS | March 31, 2026 | 557,174 | $44,078,035 | -20.3% |
| VERA | March 31, 2026 | 805,689 | $40,800,091 | -21.3% |
| ZBH | March 31, 2025 | 369,004 | $38,977,893 | -12.2% |
| MRK | Dec. 31, 2025 | 446,874 | $37,506,135 | 44.1% |
| TEVA | Sept. 30, 2025 | 2,046,846 | $34,305,139 | 84.0% |
| NTRA | March 31, 2025 | 202,646 | $32,078,862 | 129.9% |
| NUVL | June 30, 2026 | 308,506 | $31,606,440 | No longer tracked |
| SLNO | Dec. 31, 2025 | 450,585 | $30,459,546 | No longer tracked |
| ALNY | Sept. 30, 2025 | 89,525 | $29,193,207 | -49.6% |
| CI | June 30, 2025 | 73,905 | $24,314,745 | -16.3% |
| VRNA | March 31, 2025 | 454,201 | $21,093,094 | No longer tracked |
| ABBV | Dec. 31, 2025 | 89,621 | $20,750,846 | 15.5% |
| VRNA | Sept. 30, 2025 | 216,578 | $20,483,947 | No longer tracked |
| AVDL | March 31, 2025 | 1,937,984 | $20,368,212 | No longer tracked |
| BMY | March 31, 2025 | 355,366 | $20,099,501 | 8.3% |
| JAZZ | March 31, 2025 | 161,812 | $19,927,148 | 101.7% |
| INSP | Sept. 30, 2025 | 149,244 | $19,367,394 | -18.2% |
| UNH | Sept. 30, 2025 | 60,584 | $18,900,390 | 12.2% |
| IDXX | March 31, 2025 | 44,972 | $18,593,224 | 30.2% |
| MCK | June 30, 2025 | 26,944 | $18,133,043 | 16.9% |
| NVO | March 31, 2025 | 209,984 | $18,062,824 | -32.7% |
| KRRO | Dec. 31, 2025 | 337,764 | $16,175,518 | 66.5% |
| XENE | Dec. 31, 2025 | 366,102 | $14,698,995 | 34.3% |
| UNH | March 31, 2025 | 28,115 | $14,222,254 | -26.0% |
| JANX | March 31, 2025 | 236,407 | $12,657,231 | -34.9% |
| LEGN | March 31, 2025 | 388,704 | $12,648,428 | -35.8% |
| EOLS | Sept. 30, 2025 | 1,239,031 | $11,411,476 | 35.2% |
| AVDL | Dec. 31, 2025 | 724,859 | $11,068,597 | No longer tracked |
| GILD | June 30, 2025 | 89,453 | $10,023,209 | 30.6% |
| ILMN | June 30, 2025 | 120,729 | $9,578,639 | 120.1% |
| GERN | March 31, 2025 | 2,472,836 | $8,753,839 | -2.2% |
| STVN | Dec. 31, 2025 | 332,912 | $8,572,484 | 10.4% |
| INSM | June 30, 2025 | 101,859 | $7,770,823 | 24.6% |
| TARS | Dec. 31, 2025 | 119,260 | $7,087,622 | -11.7% |
| ISRG | Sept. 30, 2025 | 12,824 | $6,968,690 | -16.5% |
| MRUS | June 30, 2025 | 156,915 | $6,604,552 | No longer tracked |
| LEGN | Sept. 30, 2025 | 173,260 | $6,148,997 | -33.2% |
| NUVL | Sept. 30, 2025 | 75,973 | $5,796,740 | No longer tracked |
| MNMD | March 31, 2025 | 820,793 | $5,712,719 | No longer tracked |
| BHVN | March 31, 2025 | 140,220 | $5,237,217 | -40.7% |
| LIVN | March 31, 2025 | 99,700 | $4,617,107 | 99.2% |
| BPMC | June 30, 2025 | 50,000 | $4,425,500 | No longer tracked |
| PRAX | Dec. 31, 2025 | 75,986 | $4,027,258 | 25.4% |
| STVN | June 30, 2025 | 175,681 | $3,587,406 | -9.1% |
| WGS | Sept. 30, 2025 | 32,931 | $3,039,861 | -24.5% |
| BHVN | Dec. 31, 2025 | 149,179 | $2,239,177 | 26.3% |
| FEMY | Sept. 30, 2025 | 30,606 | $29,559 | 732.4% |